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COMMENTARY Open Access
When assessing generalisability, focusing
on differences in population or setting
alone is insufficient
Helen E. D. Burchett1* , Dylan Kneale2, Laurence Blanchard3 and James Thomas2
Abstract
Generalisability is typically only briefly mentioned in discussion sections of evaluation articles, which are unhelpful
in judging whether an intervention could be implemented elsewhere, with similar effects. Several tools to assess
generalisability exist, but they are difficult to operationalise and are rarely used. We believe a different approach is
needed. Instead of focusing on similarities (or more likely, differences) in generic population and setting
characteristics, generalisability assessments should focus on understanding an intervention’s mechanism of action -
why or how an intervention was effective. We believe changes are needed to four types of research. First, outcome
evaluations should draw on programme theory. Second, process evaluations should aim to understand
interventions’ mechanism of action, rather than simply ‘what happened’. Third, small scoping studies should be
conducted in new settings, to explore how to enact identified mechanisms. Finally, innovative synthesis methods
are required, in order to identify mechanisms of action where there is a lack of existing process evaluations.
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Background
Typically, when writing up results papers from interven-
tion evaluations, generalisability is somewhat of an after-
thought; a line or two added to the end of the discussion.
We often include some kind of token statement akin to,
‘this intervention could be generalisable to other low-
income settings’, or ‘to similar populations’. But what is
the basis of these claims? Despite the growth of the
evidence-based movement, there remains surprisingly
little evidence on how to assess generalisability. In con-
trast, more emphasis has been paid to internal validity, i.e.
whether the results of a study are ‘true’, based on the study
design and methods used. It is argued that initial studies
should focus on small populations and have high internal
validity, until causal mechanisms have been proven. Then
the intervention can be scaled up to larger studies with
more diverse populations and settings and greater external
validity. However this distinction is less clear for complex
interventions, where context and implementation are
critical to the extent of an intervention’s effect [1].
In this commentary, we argue that generalisability
statements in article discussion sections are unhelpful in
judging whether an intervention really could be imple-
mented in other settings or populations, with similar ef-
fects. These statements are typically based on observable
similarities (or more likely, differences) in generic popu-
lation and setting characteristics, regardless of whether
they might be expected to influence generalisability, and
are therefore restricted to describing ‘surface similarity’
[2]. We believe that a different approach is needed.
Assessing generalisability
Establishing the parameters of where and when evidence
may be generalisable is a complex undertaking.
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Although several frameworks and checklists have been
developed to help researchers and/or decision-makers
assess generalisability, none have been widely used [3,
4]. It could be argued that, unlike internal validity,
generalisability is a more subjective judgement and
has a tendency to be made in a less explicit manner
[5]. Yet several studies demonstrate that failure to es-
tablish generalisability directly hinders evidence use in
health decision-making [6, 7]. The plethora of differ-
ent approaches available for assessing generalisability
is not only testament to the complexity of the en-
deavour, but is also indicative of a lack of consensus
regarding the parameters of generalisability. This ap-
plies to generalising evidence from a single study,
from a systematic review or during the synthesis of
studies within a systematic review.
To illustrate our argument, we’ll consider the gener-
alisability of a weight management intervention that
was found to be effective among overweight postpar-
tum women in Gothenburg, Sweden, [8] to the Eng-
lish context. This intervention had three intervention
arms and a control arm. The most effective arm in-
volved a 12-week treatment programme where partici-
pants received an initial 1.5‑hour individual behaviour
modification counselling session with a dietician and
a 1-hour follow-up home visit in week six. In
addition, participants received a dietary modification
plan with advice on strategies, an electronic body
scale and biweekly text messages where they were
asked to report their weight.
A crude consideration of generalisability based on sur-
face similarity may lead us to decide that while the inter-
vention may be applicable to postpartum women, it
would not be applicable to women who have not re-
cently had a baby, or to men. If we look more closely at
the study population and compare it to the English con-
text, we might note that the former was older, more
educated and more likely to breastfeed than the English
postpartum population. This may lead us to conclude
that it would not be applicable to this population. How-
ever, the effects of age, education and breastfeeding on
the intervention may or may not be of critical import-
ance to the intervention’s success.
If we go beyond considerations of population and look
at the setting, we might conclude that the intervention is
generalisable to urban settings in high-income countries,
albeit ones with similar maternity leave policies and cul-
ture, comparatively low levels of income inequality, and
where there is sufficient mobile phone coverage. Further
questions could be asked about the feasibility of home
visits, provision of free weighing scales for participants
and the use of dieticians as providers. Again, we may
end up judging that the contexts in Sweden and the UK
are so different that the intervention is unlikely to be
feasible without major adaptations, which could then
alter its effectiveness.
Using existing approaches and lenses, it is easy to
reach a conclusion that the intervention will not be gen-
eralisable to most other populations or settings. Indeed,
as has been reported elsewhere, it is far easier to identify
differences and therefore to argue that an intervention is
not generalisable, than to decide that sufficient similarity
exists to allow a conclusion of ‘generalisability’ [3]. A
smaller risk is that we erroneously assume evidence is
generalisable on the basis of similarities of characteristics
that are, in fact, irrelevant to its implementation or
effectiveness.
Understanding the mechanism of action - the way in
which an intervention interacts with its context to lead
to an effect - is critical for understandings of generalis-
ability, but is all too frequently overlooked. Instead of
searching for differences in population and setting char-
acteristics as a starting point, generalisability assess-
ments should focus on understanding why or how the
intervention was effective. This type of mechanistic ac-
count of generalisability aims to identify patterns and
processes of importance to understand how interven-
tions lead to effects [9]. Instead of examining patterns of
difference, or indeed similarity, generalisability assess-
ments should begin with identifying mechanisms of ac-
tion and modifiers of importance.
For example, in the Swedish weight loss study, semi-
structured interviews were conducted with participants
to explore their experiences [10]. The researchers identi-
fied a process experienced by participants who were suc-
cessful in losing weight, but not by those who were
unsuccessful. This process involved participants initially
feeling that they were not in control of their lives and
were dissatisfied with this. There was then a ‘catalytic
interaction’ between the provider and participant, which
depended on “individualised, concrete, specific and
useful information, and an emotional bond through joint
commitment, trust and accountability” (p7 [10]). Shifting
from considering the characteristics of the population
and setting to examining the process leading to effective-
ness broadens the generalisability of the evidence beyond
urban, educated, older, breastfeeding postpartum women
in high-income countries. One could hypothesise that
this process might also occur among men, with rural
populations, or with women who were not postpartum.
Rethinking our approach to generalisability
If we take the generalisability of processes and mecha-
nisms as our starting point, then the types of evidence
we need from effectiveness research changes. A different
approach is needed if we are to improve our understand-
ing of generalisability. Understanding how an interven-
tion exerts its effect is critical at all stages of
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intervention development, evaluation and future use.
Understanding an intervention’s mechanisms of action,
and how these can be enacted in different contexts,
should enable us to develop a clearer view of whether
and how interventions could be generalizable to new
contexts. Such understandings can and should be devel-
oped, evaluated and refined at all stages in the process; a
priori theory development alone is unlikely to suffice.
First, interventions should be developed based on a clear
programme theory (e.g. theory of change) and evalua-
tions should check that the various outcomes along their
hypothesised causal pathway are being ‘triggered’ in line
with their theory.
Second, we should focus on understanding how the
intervention is implemented and experienced in context.
We need to understand its mechanisms of action and
for this we need process evaluations linked to outcome
evaluations [11]. This requires a shift in the purpose of a
process evaluation, so that they are not focused on
reporting ‘what happened’ but also aim to develop an ac-
count of ‘how things happened’ in order to understand
what the intervention’s mechanisms of action were. It
also requires us to view process evaluations as a core
output of a trial and not as an optional and less import-
ant component than outcome evaluations.
Third, once we’ve established how an intervention
worked in its original context, e.g. what the mechanisms
of action were, we can explore how to enact these mech-
anisms in a new context. This may be through small
scoping studies, rather than a large replication trial.
With the weight management example earlier, this could
include identifying what is needed in order for partici-
pants to develop an emotional bond with providers.
We also need to consolidate new methods of synthe-
sising existing literature in order to identify potential
mechanisms of action, particularly in areas that lack the
process evaluations proposed above. This could involve
the greater use of methods such as qualitative evidence
synthesis methods, [12] qualitative comparative analysis,
[13] or theoretical synthesis [14] to identify potential
mechanisms of action to test in future research. Logic
models are increasingly used in systematic reviews [15,
16] to build mechanistic accounts of how interventions
work [9] and could also be a means to assess generalis-
ability. Logic models, which are purposively designed to
elucidate the mechanisms of action and to explore how
they interact with contextual factors, could represent a
valuable, but hitherto underutilised, tool in exploring
generalisability.
Finally, there is the issue of roles and responsibilities.
If generalisability is an issue for both researchers and re-
search users to consider, then it follows that research
funding should be made available to support this work.
The broader range of methods discussed above will only
be used if funding is available. Funders need to recognise
the value of this spectrum of methods, rather than
focusing particularly on traditional outcome evaluations
and systematic reviews.
Conclusion
Overall, we believe that a better approach to the phases
of research, as can be found with clinical trials, is needed
in public health. An initial phase of research would in-
volve smaller pilot studies that test out mechanisms of
action, exploring how a given intervention may achieve
its effect. Once the mechanism is identified, then larger
trials, with integral process evaluations, can be con-
ducted. Subsequently, scoping studies could be con-
ducted to identify whether and how interventions could
be generalised to new populations and/or settings.
The benefits of these modified approaches are that
they explicitly encourage researchers (and research
users) to theorise about the generalisability of research
and develop a deeper understanding of how interven-
tions are likely to improve health outcomes. They can
identify what types of modifications may be needed for
successful implementation in new settings, without redu-
cing effectiveness. Such an approach could see the end
of statements about generalisability that are reflections
of surface similarity, and to actually provide a more use-
ful understanding of an intervention [2]. Our approach
would see ‘generalisability’ becoming less of an after-
thought and more of an integral component of research.
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